Search
- Nursing Staff, Patient, and Environmental Factors Associated with Accurate Pain Assessment - 2010-09-07
- Do Sex Differences Exist in Opioid Analgesia? A systematic review and Meta-Analysis of Human Experimental and Clinical Studies - 2010-09-07
- The Psychometric Qualities of Four Observational Pain Tools (OPTs) for the Assessment of Pain in Elderly People with Osteoarthritic Pain - 2010-09-06
- Modifiable Risk Factors for Incident Pain in Older Adults - 2010-09-06
REMS Explanation
The FDA has reopened the Federal Register for comments on the Risk Evaluation and Mitigation Strategies, or REMS, for certain opioid drug products. The new deadline for comments is October 19, 2010 which indicates that no action will be taken for at least a year. The move shows that the agency recognizes the problems identified in the comments filed about the development of an opioid REMS, which has important implications for the daily practice of clinicians, and the need to ensure a REMS does not unduly burden the health care system or limit patient access. We will monitor this development and keep you posted as needed.